TrialThe oncologist2020

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.

Sakti Chakrabarti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.